Ahn MS - Search Results

1

Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol.

Mitchell JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, Russo A. Mitchell JB, et al. Among authors: ahn ms. Arch Biochem Biophys. 1991 Aug 15;289(1):62-70. doi: 10.1016/0003-9861(91)90442-l. Arch Biochem Biophys. 1991. PMID: 1654848

2

Biologically active metal-independent superoxide dismutase mimics.

Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, Russo A. Mitchell JB, et al. Among authors: ahn ms. Biochemistry. 1990 Mar 20;29(11):2802-7. doi: 10.1021/bi00463a024. Biochemistry. 1990. PMID: 2161256

3

Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study.

Kim TH, Choi JH, Ahn MS, Lee HW, Kang SY, Choi YW, Koh YW, Sheen SS. Kim TH, et al. Among authors: ahn ms. BMC Cancer. 2024 Jan 12;24(1):70. doi: 10.1186/s12885-023-11782-6. BMC Cancer. 2024. PMID: 38216948 Free PMC article.

4

Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.

Lee YJ, Hong SJ, Kang WC, Hong BK, Lee JY, Lee JB, Cho HJ, Yoon J, Lee SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK; LODESTAR investigators. Lee YJ, et al. BMJ. 2023 Oct 18;383:e075837. doi: 10.1136/bmj-2023-075837. BMJ. 2023. PMID: 37852649 Free PMC article. Clinical Trial.

5

Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial.

Lee SJ, Kang WC, Lee JY, Lee JB, Yang TH, Yoon J, Lee YJ, Hong SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Hong BK, Jang Y, Hong MK; LODESTAR Investigators. Lee SJ, et al. EClinicalMedicine. 2023 Sep 20;64:102227. doi: 10.1016/j.eclinm.2023.102227. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37767195 Free PMC article.

6

A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13).

Kim KH, Jung M, Lee HJ, Lee SJ, Kim M, Ahn MS, Choi MY, Lee NR, Shin SJ; Korean Cancer Study Group (KCSG). Kim KH, et al. Among authors: ahn ms. Eur J Cancer. 2023 Nov;193:113312. doi: 10.1016/j.ejca.2023.113312. Epub 2023 Aug 28. Eur J Cancer. 2023. PMID: 37741071 Free article.

7

Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study.

Kim TH, Choi JH, Jeon SM, Choi YW, Kwon M, Lee HW, Kang SY, Ahn MS, Son SY, Hur H, Han SU, Sheen SS. Kim TH, et al. Among authors: ahn ms. Gastric Cancer. 2023 Nov;26(6):1012-1019. doi: 10.1007/s10120-023-01415-z. Epub 2023 Aug 30. Gastric Cancer. 2023. PMID: 37648892

8

Callus Derived from Petals of the Rosa hybrida Breeding Line 15R-12-2 as New Material Useful for Fragrance Production.

Lee KY, Shin JY, Ahn MS, Kim SJ, An HR, Kim YJ, Kwon OH, Lee SY. Lee KY, et al. Among authors: ahn ms. Plants (Basel). 2023 Aug 18;12(16):2986. doi: 10.3390/plants12162986. Plants (Basel). 2023. PMID: 37631197 Free PMC article.

9

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.

Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.

10

Highly Efficient On-Chip Photothermal Cell Lysis for Nucleic Acid Extraction Using Localized Plasmonic Heating of Strongly Absorbing Au Nanoislands.

Yu ES, Kang BH, Ahn MS, Jung JH, Park JH, Jeong KH. Yu ES, et al. Among authors: ahn ms. ACS Appl Mater Interfaces. 2023 Jul 26;15(29):34323-34331. doi: 10.1021/acsami.3c01856. Epub 2023 Jul 12. ACS Appl Mater Interfaces. 2023. PMID: 37435756 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page